Brandywine Global Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.69M Sell
26,751
-559
-2% -$161K 0.05% 298
2025
Q1
$8.42M Buy
27,310
+187
+0.7% +$57.6K 0.06% 282
2024
Q4
$9.57M Sell
27,123
-1,960
-7% -$692K 0.07% 265
2024
Q3
$10.4M Buy
29,083
+3,111
+12% +$1.11M 0.07% 261
2024
Q2
$8.27M Buy
+25,972
New +$8.27M 0.06% 299
2020
Q4
Sell
-131,194
Closed -$13.3M 675
2020
Q3
$13.3M Sell
131,194
-6,181
-4% -$624K 0.13% 164
2020
Q2
$16.6M Sell
137,375
-5,565
-4% -$673K 0.17% 132
2020
Q1
$13.6M Buy
+142,940
New +$13.6M 0.16% 135
2019
Q4
Sell
-105
Closed -$9K 876
2019
Q3
$9K Sell
105
-127,062
-100% -$10.9M ﹤0.01% 770
2019
Q2
$9.93M Sell
127,167
-11,506
-8% -$898K 0.07% 243
2019
Q1
$16.3M Buy
138,673
+282
+0.2% +$33.1K 0.11% 158
2018
Q4
$15.1M Buy
138,391
+26,035
+23% +$2.84M 0.11% 162
2018
Q3
$14.4M Buy
112,356
+112,021
+33,439% +$14.3M 0.09% 180
2018
Q2
$38K Buy
335
+216
+182% +$24.5K ﹤0.01% 793
2018
Q1
$14K Buy
119
+14
+13% +$1.65K ﹤0.01% 826
2017
Q4
$16K Sell
105
-76,461
-100% -$11.7M ﹤0.01% 810
2017
Q3
$8.97M Sell
76,566
-48,144
-39% -$5.64M 0.06% 307
2017
Q2
$16.2M Buy
124,710
+84,311
+209% +$10.9M 0.1% 175
2017
Q1
$5.47M Buy
40,399
+25,257
+167% +$3.42M 0.03% 430
2016
Q4
$2.17M Buy
15,142
+15,093
+30,802% +$2.16M 0.01% 568
2016
Q3
$6K Buy
49
+25
+104% +$3.06K ﹤0.01% 884
2016
Q2
$3K Hold
24
﹤0.01% 919
2016
Q1
$3K Sell
24
-40,848
-100% -$5.11M ﹤0.01% 952
2015
Q4
$6.4M Buy
40,872
+40,852
+204,260% +$6.4M 0.04% 368
2015
Q3
$3K Buy
+20
New +$3K ﹤0.01% 967
2014
Q4
Sell
-916
Closed -$118K 1035
2014
Q3
$118K Buy
+916
New +$118K ﹤0.01% 762
2014
Q2
Sell
-8,121
Closed -$764K 999
2014
Q1
$764K Sell
8,121
-15,679
-66% -$1.48M 0.01% 598
2013
Q4
$2.69M Sell
23,800
-150,214
-86% -$17M 0.02% 484
2013
Q3
$13.7M Buy
174,014
+25,636
+17% +$2.02M 0.14% 128
2013
Q2
$9.77M Buy
+148,378
New +$9.77M 0.1% 177